カテゴリー： GlobalInfoResearch, 世界, 部品/材料

世界の脂質有効成分市場2022年：単純脂質、複合脂質、派生脂質

◆英語タイトル：Global Lipids Active Pharmaceutical Ingredient Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY1690 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：95 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

脂質有効成分市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の脂質有効成分の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

脂質有効成分市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・単純脂質、複合脂質、派生脂質

用途別セグメントは次のように区分されます。
・循環器疾患、炎症性疾患、その他

世界の脂質有効成分市場の主要な市場プレーヤーは以下のとおりです。
・CordenPharma International、Avanti Polar Lipids、VAV Life Sciences、Sancilio＆Company、Cayman Chemical、Cerbios-Pharma SA、Merck KGaA、Esperion Therapeutics

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、脂質有効成分製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な脂質有効成分メーカーの企業概要、2019年～2022年までの脂質有効成分の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な脂質有効成分メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別脂質有効成分の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの脂質有効成分の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での脂質有効成分市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および脂質有効成分の産業チェーンを掲載しています。
・第13、14、15章では、脂質有効成分の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：CordenPharma International、Avanti Polar Lipids、VAV Life Sciences、Sancilio＆Company、Cayman Chemical、Cerbios-Pharma SA、Merck KGaA、Esperion Therapeutics
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：単純脂質、複合脂質、派生脂質
・用途別分析2017年-2028年：循環器疾患、炎症性疾患、その他
・脂質有効成分の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・脂質有効成分のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・脂質有効成分のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・脂質有効成分の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・脂質有効成分の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Lipids Active Pharmaceutical Ingredient market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Lipids Active Pharmaceutical Ingredient market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Cardiovascular Disease accounting for % of the Lipids Active Pharmaceutical Ingredient global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Simple Lipids segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Lipids Active Pharmaceutical Ingredient include CordenPharma International, Avanti Polar Lipids, VAV Life Sciences, Sancilio＆Company, and Cayman Chemical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Lipids Active Pharmaceutical Ingredient market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Simple Lipids
Compound Lipids
Derived Lipids
Market segment by Application can be divided into
Cardiovascular Disease
Inflammatory Diseases
Others
The key market players for global Lipids Active Pharmaceutical Ingredient market are listed below:
CordenPharma International
Avanti Polar Lipids
VAV Life Sciences
Sancilio＆Company
Cayman Chemical
Cerbios-Pharma SA
Merck KGaA
Esperion Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lipids Active Pharmaceutical Ingredient product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Lipids Active Pharmaceutical Ingredient, with price, sales, revenue and global market share of Lipids Active Pharmaceutical Ingredient from 2019 to 2022.
Chapter 3, the Lipids Active Pharmaceutical Ingredient competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lipids Active Pharmaceutical Ingredient breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Lipids Active Pharmaceutical Ingredient market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lipids Active Pharmaceutical Ingredient.
Chapter 13, 14, and 15, to describe Lipids Active Pharmaceutical Ingredient sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Lipids Active Pharmaceutical Ingredient Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Lipids Active Pharmaceutical Ingredient Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Simple Lipids
1.2.3 Compound Lipids
1.2.4 Derived Lipids
1.3 Market Analysis by Application
1.3.1 Overview: Global Lipids Active Pharmaceutical Ingredient Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cardiovascular Disease
1.3.3 Inflammatory Diseases
1.3.4 Others
1.4 Global Lipids Active Pharmaceutical Ingredient Market Size & Forecast
1.4.1 Global Lipids Active Pharmaceutical Ingredient Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Lipids Active Pharmaceutical Ingredient Sales in Volume (2017-2028)
1.4.3 Global Lipids Active Pharmaceutical Ingredient Price (2017-2028)
1.5 Global Lipids Active Pharmaceutical Ingredient Production Capacity Analysis
1.5.1 Global Lipids Active Pharmaceutical Ingredient Total Production Capacity (2017-2028)
1.5.2 Global Lipids Active Pharmaceutical Ingredient Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Lipids Active Pharmaceutical Ingredient Market Drivers
1.6.2 Lipids Active Pharmaceutical Ingredient Market Restraints
1.6.3 Lipids Active Pharmaceutical Ingredient Trends Analysis
2 Manufacturers Profiles
2.1 CordenPharma International
2.1.1 CordenPharma International Details
2.1.2 CordenPharma International Major Business
2.1.3 CordenPharma International Lipids Active Pharmaceutical Ingredient Product and Services
2.1.4 CordenPharma International Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Avanti Polar Lipids
2.2.1 Avanti Polar Lipids Details
2.2.2 Avanti Polar Lipids Major Business
2.2.3 Avanti Polar Lipids Lipids Active Pharmaceutical Ingredient Product and Services
2.2.4 Avanti Polar Lipids Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 VAV Life Sciences
2.3.1 VAV Life Sciences Details
2.3.2 VAV Life Sciences Major Business
2.3.3 VAV Life Sciences Lipids Active Pharmaceutical Ingredient Product and Services
2.3.4 VAV Life Sciences Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sancilio＆Company
2.4.1 Sancilio＆Company Details
2.4.2 Sancilio＆Company Major Business
2.4.3 Sancilio＆Company Lipids Active Pharmaceutical Ingredient Product and Services
2.4.4 Sancilio＆Company Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Cayman Chemical
2.5.1 Cayman Chemical Details
2.5.2 Cayman Chemical Major Business
2.5.3 Cayman Chemical Lipids Active Pharmaceutical Ingredient Product and Services
2.5.4 Cayman Chemical Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Cerbios-Pharma SA
2.6.1 Cerbios-Pharma SA Details
2.6.2 Cerbios-Pharma SA Major Business
2.6.3 Cerbios-Pharma SA Lipids Active Pharmaceutical Ingredient Product and Services
2.6.4 Cerbios-Pharma SA Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck KGaA
2.7.1 Merck KGaA Details
2.7.2 Merck KGaA Major Business
2.7.3 Merck KGaA Lipids Active Pharmaceutical Ingredient Product and Services
2.7.4 Merck KGaA Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Esperion Therapeutics
2.8.1 Esperion Therapeutics Details
2.8.2 Esperion Therapeutics Major Business
2.8.3 Esperion Therapeutics Lipids Active Pharmaceutical Ingredient Product and Services
2.8.4 Esperion Therapeutics Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Lipids Active Pharmaceutical Ingredient Breakdown Data by Manufacturer
3.1 Global Lipids Active Pharmaceutical Ingredient Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Lipids Active Pharmaceutical Ingredient Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Lipids Active Pharmaceutical Ingredient
3.4 Market Concentration Rate
3.4.1 Top 3 Lipids Active Pharmaceutical Ingredient Manufacturer Market Share in 2021
3.4.2 Top 6 Lipids Active Pharmaceutical Ingredient Manufacturer Market Share in 2021
3.5 Global Lipids Active Pharmaceutical Ingredient Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Lipids Active Pharmaceutical Ingredient Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Lipids Active Pharmaceutical Ingredient Market Size by Region
4.1.1 Global Lipids Active Pharmaceutical Ingredient Sales in Volume by Region (2017-2028)
4.1.2 Global Lipids Active Pharmaceutical Ingredient Revenue by Region (2017-2028)
4.2 North America Lipids Active Pharmaceutical Ingredient Revenue (2017-2028)
4.3 Europe Lipids Active Pharmaceutical Ingredient Revenue (2017-2028)
4.4 Asia-Pacific Lipids Active Pharmaceutical Ingredient Revenue (2017-2028)
4.5 South America Lipids Active Pharmaceutical Ingredient Revenue (2017-2028)
4.6 Middle East and Africa Lipids Active Pharmaceutical Ingredient Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Lipids Active Pharmaceutical Ingredient Sales in Volume by Type (2017-2028)
5.2 Global Lipids Active Pharmaceutical Ingredient Revenue by Type (2017-2028)
5.3 Global Lipids Active Pharmaceutical Ingredient Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Lipids Active Pharmaceutical Ingredient Sales in Volume by Application (2017-2028)
6.2 Global Lipids Active Pharmaceutical Ingredient Revenue by Application (2017-2028)
6.3 Global Lipids Active Pharmaceutical Ingredient Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Lipids Active Pharmaceutical Ingredient Sales by Type (2017-2028)
7.2 North America Lipids Active Pharmaceutical Ingredient Sales by Application (2017-2028)
7.3 North America Lipids Active Pharmaceutical Ingredient Market Size by Country
7.3.1 North America Lipids Active Pharmaceutical Ingredient Sales in Volume by Country (2017-2028)
7.3.2 North America Lipids Active Pharmaceutical Ingredient Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Lipids Active Pharmaceutical Ingredient Sales by Type (2017-2028)
8.2 Europe Lipids Active Pharmaceutical Ingredient Sales by Application (2017-2028)
8.3 Europe Lipids Active Pharmaceutical Ingredient Market Size by Country
8.3.1 Europe Lipids Active Pharmaceutical Ingredient Sales in Volume by Country (2017-2028)
8.3.2 Europe Lipids Active Pharmaceutical Ingredient Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales by Type (2017-2028)
9.2 Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales by Application (2017-2028)
9.3 Asia-Pacific Lipids Active Pharmaceutical Ingredient Market Size by Region
9.3.1 Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Lipids Active Pharmaceutical Ingredient Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Lipids Active Pharmaceutical Ingredient Sales by Type (2017-2028)
10.2 South America Lipids Active Pharmaceutical Ingredient Sales by Application (2017-2028)
10.3 South America Lipids Active Pharmaceutical Ingredient Market Size by Country
10.3.1 South America Lipids Active Pharmaceutical Ingredient Sales in Volume by Country (2017-2028)
10.3.2 South America Lipids Active Pharmaceutical Ingredient Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales by Type (2017-2028)
11.2 Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales by Application (2017-2028)
11.3 Middle East & Africa Lipids Active Pharmaceutical Ingredient Market Size by Country
11.3.1 Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Lipids Active Pharmaceutical Ingredient Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Lipids Active Pharmaceutical Ingredient and Key Manufacturers
12.2 Manufacturing Costs Percentage of Lipids Active Pharmaceutical Ingredient
12.3 Lipids Active Pharmaceutical Ingredient Production Process
12.4 Lipids Active Pharmaceutical Ingredient Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Lipids Active Pharmaceutical Ingredient Typical Distributors
13.3 Lipids Active Pharmaceutical Ingredient Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Lipids Active Pharmaceutical Ingredient Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Lipids Active Pharmaceutical Ingredient Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. CordenPharma International Basic Information, Manufacturing Base and Competitors
Table 4. CordenPharma International Major Business
Table 5. CordenPharma International Lipids Active Pharmaceutical Ingredient Product and Services
Table 6. CordenPharma International Lipids Active Pharmaceutical Ingredient Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Avanti Polar Lipids Basic Information, Manufacturing Base and Competitors
Table 8. Avanti Polar Lipids Major Business
Table 9. Avanti Polar Lipids Lipids Active Pharmaceutical Ingredient Product and Services
Table 10. Avanti Polar Lipids Lipids Active Pharmaceutical Ingredient Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. VAV Life Sciences Basic Information, Manufacturing Base and Competitors
Table 12. VAV Life Sciences Major Business
Table 13. VAV Life Sciences Lipids Active Pharmaceutical Ingredient Product and Services
Table 14. VAV Life Sciences Lipids Active Pharmaceutical Ingredient Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sancilio＆Company Basic Information, Manufacturing Base and Competitors
Table 16. Sancilio＆Company Major Business
Table 17. Sancilio＆Company Lipids Active Pharmaceutical Ingredient Product and Services
Table 18. Sancilio＆Company Lipids Active Pharmaceutical Ingredient Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Cayman Chemical Basic Information, Manufacturing Base and Competitors
Table 20. Cayman Chemical Major Business
Table 21. Cayman Chemical Lipids Active Pharmaceutical Ingredient Product and Services
Table 22. Cayman Chemical Lipids Active Pharmaceutical Ingredient Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Cerbios-Pharma SA Basic Information, Manufacturing Base and Competitors
Table 24. Cerbios-Pharma SA Major Business
Table 25. Cerbios-Pharma SA Lipids Active Pharmaceutical Ingredient Product and Services
Table 26. Cerbios-Pharma SA Lipids Active Pharmaceutical Ingredient Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 28. Merck KGaA Major Business
Table 29. Merck KGaA Lipids Active Pharmaceutical Ingredient Product and Services
Table 30. Merck KGaA Lipids Active Pharmaceutical Ingredient Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Esperion Therapeutics Basic Information, Manufacturing Base and Competitors
Table 32. Esperion Therapeutics Major Business
Table 33. Esperion Therapeutics Lipids Active Pharmaceutical Ingredient Product and Services
Table 34. Esperion Therapeutics Lipids Active Pharmaceutical Ingredient Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Lipids Active Pharmaceutical Ingredient Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kiloton)
Table 36. Global Lipids Active Pharmaceutical Ingredient Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Lipids Active Pharmaceutical Ingredient, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Lipids Active Pharmaceutical Ingredient Production Capacity by Company, (Kiloton): 2020 VS 2021
Table 39. Head Office and Lipids Active Pharmaceutical Ingredient Production Site of Key Manufacturer
Table 40. Lipids Active Pharmaceutical Ingredient New Entrant and Capacity Expansion Plans
Table 41. Lipids Active Pharmaceutical Ingredient Mergers & Acquisitions in the Past Five Years
Table 42. Global Lipids Active Pharmaceutical Ingredient Sales by Region (2017-2022) & (Kiloton)
Table 43. Global Lipids Active Pharmaceutical Ingredient Sales by Region (2023-2028) & (Kiloton)
Table 44. Global Lipids Active Pharmaceutical Ingredient Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Lipids Active Pharmaceutical Ingredient Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Lipids Active Pharmaceutical Ingredient Sales by Type (2017-2022) & (Kiloton)
Table 47. Global Lipids Active Pharmaceutical Ingredient Sales by Type (2023-2028) & (Kiloton)
Table 48. Global Lipids Active Pharmaceutical Ingredient Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Lipids Active Pharmaceutical Ingredient Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Lipids Active Pharmaceutical Ingredient Price by Type (2017-2022) & (US$/Ton)
Table 51. Global Lipids Active Pharmaceutical Ingredient Price by Type (2023-2028) & (US$/Ton)
Table 52. Global Lipids Active Pharmaceutical Ingredient Sales by Application (2017-2022) & (Kiloton)
Table 53. Global Lipids Active Pharmaceutical Ingredient Sales by Application (2023-2028) & (Kiloton)
Table 54. Global Lipids Active Pharmaceutical Ingredient Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Lipids Active Pharmaceutical Ingredient Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Lipids Active Pharmaceutical Ingredient Price by Application (2017-2022) & (US$/Ton)
Table 57. Global Lipids Active Pharmaceutical Ingredient Price by Application (2023-2028) & (US$/Ton)
Table 58. North America Lipids Active Pharmaceutical Ingredient Sales by Country (2017-2022) & (Kiloton)
Table 59. North America Lipids Active Pharmaceutical Ingredient Sales by Country (2023-2028) & (Kiloton)
Table 60. North America Lipids Active Pharmaceutical Ingredient Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Lipids Active Pharmaceutical Ingredient Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Lipids Active Pharmaceutical Ingredient Sales by Type (2017-2022) & (Kiloton)
Table 63. North America Lipids Active Pharmaceutical Ingredient Sales by Type (2023-2028) & (Kiloton)
Table 64. North America Lipids Active Pharmaceutical Ingredient Sales by Application (2017-2022) & (Kiloton)
Table 65. North America Lipids Active Pharmaceutical Ingredient Sales by Application (2023-2028) & (Kiloton)
Table 66. Europe Lipids Active Pharmaceutical Ingredient Sales by Country (2017-2022) & (Kiloton)
Table 67. Europe Lipids Active Pharmaceutical Ingredient Sales by Country (2023-2028) & (Kiloton)
Table 68. Europe Lipids Active Pharmaceutical Ingredient Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Lipids Active Pharmaceutical Ingredient Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Lipids Active Pharmaceutical Ingredient Sales by Type (2017-2022) & (Kiloton)
Table 71. Europe Lipids Active Pharmaceutical Ingredient Sales by Type (2023-2028) & (Kiloton)
Table 72. Europe Lipids Active Pharmaceutical Ingredient Sales by Application (2017-2022) & (Kiloton)
Table 73. Europe Lipids Active Pharmaceutical Ingredient Sales by Application (2023-2028) & (Kiloton)
Table 74. Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales by Region (2017-2022) & (Kiloton)
Table 75. Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales by Region (2023-2028) & (Kiloton)
Table 76. Asia-Pacific Lipids Active Pharmaceutical Ingredient Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Lipids Active Pharmaceutical Ingredient Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales by Type (2017-2022) & (Kiloton)
Table 79. Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales by Type (2023-2028) & (Kiloton)
Table 80. Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales by Application (2017-2022) & (Kiloton)
Table 81. Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales by Application (2023-2028) & (Kiloton)
Table 82. South America Lipids Active Pharmaceutical Ingredient Sales by Country (2017-2022) & (Kiloton)
Table 83. South America Lipids Active Pharmaceutical Ingredient Sales by Country (2023-2028) & (Kiloton)
Table 84. South America Lipids Active Pharmaceutical Ingredient Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Lipids Active Pharmaceutical Ingredient Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Lipids Active Pharmaceutical Ingredient Sales by Type (2017-2022) & (Kiloton)
Table 87. South America Lipids Active Pharmaceutical Ingredient Sales by Type (2023-2028) & (Kiloton)
Table 88. South America Lipids Active Pharmaceutical Ingredient Sales by Application (2017-2022) & (Kiloton)
Table 89. South America Lipids Active Pharmaceutical Ingredient Sales by Application (2023-2028) & (Kiloton)
Table 90. Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales by Region (2017-2022) & (Kiloton)
Table 91. Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales by Region (2023-2028) & (Kiloton)
Table 92. Middle East & Africa Lipids Active Pharmaceutical Ingredient Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Lipids Active Pharmaceutical Ingredient Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales by Type (2017-2022) & (Kiloton)
Table 95. Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales by Type (2023-2028) & (Kiloton)
Table 96. Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales by Application (2017-2022) & (Kiloton)
Table 97. Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales by Application (2023-2028) & (Kiloton)
Table 98. Lipids Active Pharmaceutical Ingredient Raw Material
Table 99. Key Manufacturers of Lipids Active Pharmaceutical Ingredient Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Lipids Active Pharmaceutical Ingredient Typical Distributors
Table 103. Lipids Active Pharmaceutical Ingredient Typical Customers
List of Figures
Figure 1. Lipids Active Pharmaceutical Ingredient Picture
Figure 2. Global Lipids Active Pharmaceutical Ingredient Revenue Market Share by Type in 2021
Figure 3. Simple Lipids
Figure 4. Compound Lipids
Figure 5. Derived Lipids
Figure 6. Global Lipids Active Pharmaceutical Ingredient Revenue Market Share by Application in 2021
Figure 7. Cardiovascular Disease
Figure 8. Inflammatory Diseases
Figure 9. Others
Figure 10. Global Lipids Active Pharmaceutical Ingredient Revenue, (USD Million) & (Kiloton): 2017 & 2021 & 2028
Figure 11. Global Lipids Active Pharmaceutical Ingredient Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Lipids Active Pharmaceutical Ingredient Sales (2017-2028) & (Kiloton)
Figure 13. Global Lipids Active Pharmaceutical Ingredient Price (2017-2028) & (US$/Ton)
Figure 14. Global Lipids Active Pharmaceutical Ingredient Production Capacity (2017-2028) & (Kiloton)
Figure 15. Global Lipids Active Pharmaceutical Ingredient Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Lipids Active Pharmaceutical Ingredient Market Drivers
Figure 17. Lipids Active Pharmaceutical Ingredient Market Restraints
Figure 18. Lipids Active Pharmaceutical Ingredient Market Trends
Figure 19. Global Lipids Active Pharmaceutical Ingredient Sales Market Share by Manufacturer in 2021
Figure 20. Global Lipids Active Pharmaceutical Ingredient Revenue Market Share by Manufacturer in 2021
Figure 21. Lipids Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Lipids Active Pharmaceutical Ingredient Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Lipids Active Pharmaceutical Ingredient Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Lipids Active Pharmaceutical Ingredient Sales Market Share by Region (2017-2028)
Figure 25. Global Lipids Active Pharmaceutical Ingredient Revenue Market Share by Region (2017-2028)
Figure 26. North America Lipids Active Pharmaceutical Ingredient Revenue (2017-2028) & (USD Million)
Figure 27. Europe Lipids Active Pharmaceutical Ingredient Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Lipids Active Pharmaceutical Ingredient Revenue (2017-2028) & (USD Million)
Figure 29. South America Lipids Active Pharmaceutical Ingredient Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Lipids Active Pharmaceutical Ingredient Revenue (2017-2028) & (USD Million)
Figure 31. Global Lipids Active Pharmaceutical Ingredient Sales Market Share by Type (2017-2028)
Figure 32. Global Lipids Active Pharmaceutical Ingredient Revenue Market Share by Type (2017-2028)
Figure 33. Global Lipids Active Pharmaceutical Ingredient Price by Type (2017-2028) & (US$/Ton)
Figure 34. Global Lipids Active Pharmaceutical Ingredient Sales Market Share by Application (2017-2028)
Figure 35. Global Lipids Active Pharmaceutical Ingredient Revenue Market Share by Application (2017-2028)
Figure 36. Global Lipids Active Pharmaceutical Ingredient Price by Application (2017-2028) & (US$/Ton)
Figure 37. North America Lipids Active Pharmaceutical Ingredient Sales Market Share by Type (2017-2028)
Figure 38. North America Lipids Active Pharmaceutical Ingredient Sales Market Share by Application (2017-2028)
Figure 39. North America Lipids Active Pharmaceutical Ingredient Sales Market Share by Country (2017-2028)
Figure 40. North America Lipids Active Pharmaceutical Ingredient Revenue Market Share by Country (2017-2028)
Figure 41. United States Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Lipids Active Pharmaceutical Ingredient Sales Market Share by Type (2017-2028)
Figure 45. Europe Lipids Active Pharmaceutical Ingredient Sales Market Share by Application (2017-2028)
Figure 46. Europe Lipids Active Pharmaceutical Ingredient Sales Market Share by Country (2017-2028)
Figure 47. Europe Lipids Active Pharmaceutical Ingredient Revenue Market Share by Country (2017-2028)
Figure 48. Germany Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Lipids Active Pharmaceutical Ingredient Revenue Market Share by Region (2017-2028)
Figure 57. China Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Lipids Active Pharmaceutical Ingredient Sales Market Share by Type (2017-2028)
Figure 64. South America Lipids Active Pharmaceutical Ingredient Sales Market Share by Application (2017-2028)
Figure 65. South America Lipids Active Pharmaceutical Ingredient Sales Market Share by Country (2017-2028)
Figure 66. South America Lipids Active Pharmaceutical Ingredient Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Lipids Active Pharmaceutical Ingredient Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Lipids Active Pharmaceutical Ingredient in 2021
Figure 78. Manufacturing Process Analysis of Lipids Active Pharmaceutical Ingredient
Figure 79. Lipids Active Pharmaceutical Ingredient Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の脂質有効成分市場2022年：単純脂質、複合脂質、派生脂質(Global Lipids Active Pharmaceutical Ingredient Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の脂質有効成分市場2022年：単純脂質、複合脂質、派生脂質

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp